Physician profile
David A Hensley
NPI 1164417275
$3,291.80
in general payments reported to CMS, 2019-2025
25 companies · $427 in 2025
The $427 reported for 2025 was more than what 91% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $301 · 2020: $554 · 2021: $372 · 2022: $459 · 2023: $566 · 2024: $614 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,607.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,606.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $594.86 | 2019-2025 | Dyanavel Xr, Quillichew Er, Quillivant |
| Corium, LLC | $456.14 | 2022-2025 | Azstarys |
| Ironshore Pharmaceuticals INC. | $426.05 | 2019-2024 | Jornay Pm |
| Supernus Pharmaceuticals, INC. | $293.09 | 2021-2025 | Qelbree, Qelbree |
| Takeda Pharmaceuticals U.S.A., INC. | $238.19 | 2019-2022 | |
| Sanofi Pasteur INC. | $179.43 | 2020-2025 | |
| Pfizer INC. | $170.25 | 2019-2024 | |
| Collegium Pharmaceutical, INC. | $160.68 | 2025 | Jornay Pm |
| Merck Sharp & Dohme LLC | $126.17 | 2022-2025 | Vaxneuvance, Gardasil 9, Gardasil |
| Neos Therapeutics, LP | $115.02 | 2022-2024 | Cotempla Xr-Odt |
| Glaxosmithkline, LLC. | $105.52 | 2019-2024 | Bexsero |
| Tempus Ai, INC | $91.94 | 2024 | |
| Novartis Pharmaceuticals Corporation | $70.47 | 2024 | |
| Sanofi-Aventis U.S. LLC | $46.09 | 2025 | |
| Ultragenyx Pharmaceutical INC. | $32.06 | 2021 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sobi, INC | $28.50 | 2020-2022 | |
| Biogen, INC. | $27.89 | 2024 | Skyclarys |
| Cranial Technologies, INC | $19.33 | 2025 | Doc Band |
| Nestle Healthcare Nutrition INC. | $18.91 | 2023 | |
| Seqirus USA INC | $17.62 | 2021 | |
| Organon LLC | $17.51 | 2022 | |
| Adlon Therapeutics L.P. | $14.50 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $14.13 | 2025 | Zoryve |
| Allergan, INC. | $13.88 | 2020 | |
| Mission Pharmacal Company | $13.57 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Hensley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.